lobbying_activities: 2773008

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2773008	83cc059c-dfb7-4073-83c3-28bdc0038e91	Q1	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2022	first_quarter	MED	AACC joined with other healthcare groups in writing to the Senate HELP leadership endorsing S.3534, the Tracking Pathogens Act, which would support and enhance existing genomic sequencing and surveillance activities. AACC met with House and Senate staff urging that the Verifying Accurate Leading-edge IVCT Development (VALID) Act not be included in the Medical Device User Fee Amendments V legislative package that will be considered by Congress. AACC provided input to the Senate HELP committee on its draft "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act," which would rebuild and strengthen our nations public health infrastructure.	HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2022-04-13T14:50:02-04:00